New funding awards - March 2021

Monday, April 19, 2021

Sponsored Research

Geoffrey Ginsburg of Cardiology has received an award (5U01-HG010225-03S4) from the National Institutes of Health for a project entitled "The IGNITE II CC: Engagement, Coordination, Demonstration, and Dissemination." Total funding will be $280,812.

Peter Weng (Mentor: Diego Bohorquez) of Gastroenterology has received an award (1F30-DK127650-01) from the National Institutes of Health for a project entitled "Sensing Dietary Amino Acids from Gut to Brain." Total funding will be $145,848.

Andrew Muir of Gastroenterology has received an award from the GENFIT for a project entitled "A Double-blind, Randomized, Placebo-Controlled Study and Open-label Long Term Extension to Evaluate the Efficacy and Safety of Elafibranor 80 mg in Patients with Primary Biliary Cholangitis with Inadequate Response or Intolerance to Ursodeoxycholic A." Total funding will be $203,807.

Nelson Chao of Hematologic Malignancies and Cellular Therapy has received an award (2U19-AI067798-16) from the National Institutes of Health for a project entitled "Administration Core." Total funding will be $11,475,100.

Nelson Chao of Hematologic Malignancies and Cellular Therapy has received a sub-award (N00014-17-1-2388) through the National Marrow Donor Program for a project entitled "RITN 2021." Total funding will be $1.

Nelson Chao of Hematologic Malignancies and Cellular Therapy has received an award (2U19-AI067798-16) from the National Institutes of Health for a project entitled "Project 1 CaMKK2: a novel target to mitigate radiation induced injury of the hematopoietic system and the gastrointestinal tract." Total funding will be $0.

Phuong Doan of Hematologic Malignancies and Cellular Therapy has received an award (2U19-AI067798-16) from the National Institutes of Health for a project entitled "Project 2 Endothelial Cell-Derived Extracellular Vesicles for Mitigation of the Hematopoietic Acute Radiation Syndrome, a part of Nelson J. Chao's project entitled "Centers for Medical Countermeasures against Radiation Consortium"." Total funding will be $0.

Nirmish Shah of Hematology has received a sub-award (1UG3-AT011265-01) through the University of Illinois at Chicago for a project entitled "Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain." Total funding will be $60,325.

John Perfect of Infectious Diseases has received an award from the European Union for a project entitled "Host directed medicine in invasive fungal infection - HDM-FUN." Total funding will be $654,520.

Christine F. Markwalter (Mentor: Steve Taylor) of Infectious Diseases has received an award (1F32-AI149950-01A1) from the National Institutes of Health for a project entitled "Antibody biomarker discovery for current and recent asymptomatic malaria exposure." Total funding will be $135,636.

Kelly Marcom of Medical Oncology has received an award from the Johns Hopkins University for a project entitled "Translational Breast Cancer Research Consortium 2020 Infrastructure (BCRF)." Total funding will be $37,500.

Kelly Marcom of Medical Oncology has received an award from the Johns Hopkins University for a project entitled "Translational Breast Cancer Research Consortium 2020 Infrastructure - SGK." Total funding will be $37,500.

Scott Palmer of Pulmonary has received an award (1R21-TR003037-01A1) from the National Institutes of Health for a project entitled "Proof of Concept Treatment Interventions in a Rodent Model of the Rare Disease Bronchiolitis Obliterans." Total funding will be $442,750.

Loretta Que of Pulmonary has received an award from the American Lung Association for a project entitled "American Lung Association-Airways Clinical Research Center-Lung Health Cohort (ALA-LHC)." Total funding will be $10,500.

Industry-sponsored Clinical Trials

Adam DeVore of Cardiology has received an award from BodyPort for a project entitled "BODYPORT - Protocol Dev - Industry." Total funding will be $1,010,489.

Adam DeVore of Cardiology has received an award from Amgen, Inc. for a project entitled "HF-Evolution." Total funding will be $255,715.

Ravi Karra of Cardiology has received an award from MyoKardia, Inc. for a project entitled "MYK-461-019 (EMBARK)." Total funding will be $331,127.

Michel Khouri of Cardiology has received an award from Moleculin Biotech, Inc. for a project entitled "MB-107 Annamycin II Sarcoma." Total funding will be $170,813.

Martin Moseley III of Cardiology has received an award from Circumvent Pharmaceutical for a project entitled "Perform acyl-RAC on Cln3 brain samples (Addendum #3)." Total funding will be $17,290.

Sean Pokorney of Cardiology has received an award from Boston Scientific Corporation for a project entitled "LUX PERFORM." Total funding will be $474,596.

Sudarshan Rajagopal of Cardiology has received an award from Janssen Research & Development, LLC for a project entitled "NAPUH001 CIPHER." Total funding will be $13,000.

David Leiman of Gastroenterology has received an award from Allakos Inc. for a project entitled "A Phase 3, Multicenter, Open-Label, Extension Study to Evaluate the Efficacy and Safety of AK002 in Patients That Were Previously Enrolled in AK002-016 or AK002-012 Studies and have Eosinophilic Gastritis and/or Eosinophilic Duodenitis." Total funding will be $229,274.

Harry Erba of Hematologic Malignancies and Cellular Therapy has received an award from Ascentage Pharma Group for a project entitled "A Phase Ib/II Study of APG-115 Alone or in Combination with Azacitidine in Patients with Relapse/Refractory AML." Total funding will be $360,922.

Lindsay Rein of Hematologic Malignancies and Cellular Therapy has received an award from Kiadis Pharma for a project entitled "A Phase I Trial of Incorporating Natural Killer (K-NK) cells for Patients with Chronic Myeloid Leukemia (CML) and Molecular Residual Disease After Tyrosine Kinase Inhibitor (TKI) Therapy." Total funding will be $89,172.

Thuy Le of Infectious Diseases has received an award from Gilead Sciences, Inc. for a project entitled "Gilead Investigator Initiated Study." Total funding will be $719,877.

Andrew Armstrong of Medical Oncology has received an award from Bristol-Myers Squibb Company for a project entitled "A Phase II, Single Arm Study of Chemoimmunotherapy for the Treatment of Men with Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer (CHAMP)." Total funding will be $999,662.

Jennifer Choe of Medical Oncology has received an award from Merck Sharp & Dohme for a project entitled "A Phase 2 Study in First Line Metastatic or Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma to Evaluate Intratumoral MK-1454 in Combination with IV Pembrolizumab vs IV Pembrolizumab Monotherapy." Total funding will be $758,728.

April Salama of Medical Oncology has received an award from Merck Sharp & Dohme for a project entitled "A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Design of Investigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Participants With Melanoma (KEYMAKER-U02): Substudy 02D." Total funding will be $696,469.

April Salama of Medical Oncology has received an award from Merck Sharp & Dohme for a project entitled "A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Design of Investigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Participants with Melanoma (KEYNOTE-U02): Substudy 02C." Total funding will be $620,630.

April Salama of Medical Oncology has received an award from Bristol-Myers Squibb Company for a project entitled "A Phase 3, Randomized, Double-Blind Study of Adjuvant Immunotherapy with Nivolumab versus Placebo after Complete Resection of Stage IIB/C Melanoma (CheckMate 76K: CHECKpoint pathway and nivoluMAb clinical Trial Evaluation 76K)." Total funding will be $376,741.

Thomas Stinchcombe of Medical Oncology has received an award from Mirati Therapeutics, Inc. for a project entitled "This Phase 2 study evaluates the clinical activity and safety of MRTX849 in combination with pembrolizumab in cohorts of patients with advanced NSCLC with KRAS G12C mutation and any PD-L1 Tumor Proportion Score.." Total funding will be $187,887.

Opeyemi Olabisi of Nephrology has received an award from Icagen, Inc for a project entitled "Icagen SRA." Total funding will be $164,764.

Yuh Chin Huang of Pulmonary has received an award from Genentech, Inc. for a project entitled "GE42063 Xe MRI Assessment of disease progression in patients with COPD w/standard of care medications with or without daily open label Azithromycin treatment to prevent acute exacerbation." Total funding will be $718,767.

Bryan Kraft of Pulmonary has received an award from Grifols Worldwide Operations for a project entitled "ICU COVID-19 Biorepository Plasma Samples." Total funding will be $24,633.

Kamran Mahmood of Pulmonary has received an award from Known Medicine for a project entitled "Known Medicine Pleural Fluid Samples." Total funding will be $14,500.

Megan Clowse of Rheumatology has received an award from GlaxoSmithKline for a project entitled "Biomarkers of Pregnancy Complications in women with Rheumatic Disease." Total funding will be $416,740.

Catherine A. Sims (Mentor: Megan Clowse) of Rheumatology has received an award from UCB Biosciences Inc. for a project entitled "UCB Women's Health Fellowship Program - Catherine Sims." Total funding will be $100,000.